US2006084060A1PendingUtilityA1
Gel having biosubstance fixed thereto and microarray utilizing the gel
Est. expiryApr 3, 2022(expired)· nominal 20-yr term from priority
B01J 2219/00596B01J 2219/00644B01J 2219/00585B01J 2219/00659G01N 33/53B01J 2219/00641B01J 19/0046B01J 2219/00317B01J 2219/00576C12M 1/00B01J 2219/00722B01J 2219/00524B01J 2219/0052B01J 2219/00673B01J 2219/00639G01N 37/00Y10T428/1352
29
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides a biological substance-immobilized gel which comprises a gel containing 2%-7% by mass of N,N-dimethylacrylamide and a biological substance immobilized on and/or in the gel.
Claims
exact text as granted — not AI-modified1 . A biological substance-immobilized gel which comprises a gel containing 2%-7% by mass of N,N-dimethylacrylamide and a biological substance immobilized on and/or in the gel.
2 . A biological substance-immobilized gel which comprises a gel having the following composition and a biological substance immobilized on and/or in the gel:
(a) N,N-dimethylacrylamide
2% to 7% by mass
(b) cross-linking agent
0.1% to 1.5% by mass.
3 . The biological substance-immobilized gel according to claim 1 or 2 , wherein the biological substance is a nucleic acid.
4 . The biological substance-immobilized gel according to claim 2 or 3 , wherein the cross-linking agent is a multifunctional monomer having at least two ethylenically unsaturated bonds.
5 . The biological substance-immobilized gel according to claim 4 , wherein the cross-linking agent is methylenebisacrylamide.
6 . A method for preparing a biological substance-immobilized gel, which comprises immobilizing a biological substance on and/or in a gel containing 2%-7% by mass of N,N-dimethylacrylamide.
7 . The method according to claim 6 , wherein the gel is obtained by reacting 2%-7% by mass of N,N-dimethylacrylamide in the presence of 0.1%-1.5% by mass of a cross-linking agent.
8 . A gel-filled hollow tube which comprises a hollow tube whose hollow space is filled with the biological substance-immobilized gel according to any one of claims 1 to 5 .
9 . The gel-filled hollow tube according to claim 8 , wherein the hollow tube is a hollow fiber.
10 . A method for manufacturing a biological substance-immobilized gel microarray, which comprises allowing a plurality of gel-filled hollow tubes according to claim 8 or 9 to be tied in a bundle and cutting the resulting tube bundle in a direction intersecting with the longitudinal direction of the tubes.
11 . A method for manufacturing a biological substance-immobilized gel microarray, which comprises the following steps:
(1) allowing a plurality of hollow tubes to be tied in a bundle; (2) filling the biological substance-immobilized gel according to any one of claims 1 to 5 into the hollow space of each tube in the resulting tube bundle; and (3) cutting the tube bundle in a direction intersecting with the longitudinal direction of the tubes.
12 . A biological substance-immobilized gel microarray which comprises the biological substance-immobilized gel according to any one of claims 1 to 5 , wherein the gel is arranged in multiple compartments.
13 . The biological substance-immobilized gel microarray according to claim 12 , wherein the surface area of each compartment is 10 −6 m 2 or less.
14 . The biological substance-immobilized gel microarray according to claim 12 or 13 , wherein the compartments are formed by slots or through holes.
15 . A biological substance-immobilized gel microarray which is obtained by allowing a plurality of gel-filled hollow tubes according to claim 8 or 9 to be tied in a bundle and cutting the tube bundle in a direction intersecting with the longitudinal direction of the tubes.
16 . The biological substance-immobilized gel microarray according to claim 15 , wherein the hollow tubes are hollow fibers.
17 . A method for detecting a target to be measured, which comprises reacting an analyte with the microarray according to any one of claims 12 to 16 and detecting the target in the analyte.
18 . The method according to claim 17 , wherein the target to be measured is a nucleic acid.
19 . The method according to claim 18 , wherein the nucleic acid is 100 nucleotides or less in length.Join the waitlist — get patent alerts
Track US2006084060A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.